Cardiology devices as a category fared well in the Medicare inpatient rule for fiscal 2019, but Claret Medical Inc. of Santa Rosa, Calif., was perhaps the biggest winner. The company snared a new technology add-on payment for its Sentinel embolic filter device for use during aortic valve procedures, which in turn sparked an additional $50 million payment from Boston Scientific in its acquisition of Claret in a deal announced only two weeks ago. (See BioWorld MedTech, July 23, 2018.)